Autologous Matrix-induced Chondrogenesis Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Autologous Matrix-induced Chondrogenesis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Matrix-induced Chondrogenesis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Matrix-induced Chondrogenesis Overall Market Size
2.1 Global Autologous Matrix-induced Chondrogenesis Market Size: 2021 VS 2027
2.2 Global Autologous Matrix-induced Chondrogenesis Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autologous Matrix-induced Chondrogenesis Players in Global Market
3.2 Top Global Autologous Matrix-induced Chondrogenesis Companies Ranked by Revenue
3.3 Global Autologous Matrix-induced Chondrogenesis Revenue by Companies
3.4 Top 3 and Top 5 Autologous Matrix-induced Chondrogenesis Companies in Global Market, by Revenue in 2020
3.5 Global Companies Autologous Matrix-induced Chondrogenesis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autologous Matrix-induced Chondrogenesis Players in Global Market
3.6.1 List of Global Tier 1 Autologous Matrix-induced Chondrogenesis Companies
3.6.2 List of Global Tier 2 and Tier 3 Autologous Matrix-induced Chondrogenesis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Autologous Matrix-induced Chondrogenesis Market Size Markets, 2021 & 2027
4.1.2 Hyaluronic Acid
4.1.3 Collagen
4.1.4 Polyethylene Glycol (PEG)
4.1.5 Poly Lactic-Co-Glycolic Acid (PGLA)
4.2 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue & Forecasts
4.2.1 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue, 2016-2021
4.2.2 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue, 2022-2027
4.2.3 By Type - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autologous Matrix-induced Chondrogenesis Market Size, 2021 & 2027
5.1.2 Knees Joint
5.1.3 Other
5.2 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue & Forecasts
5.2.1 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue, 2016-2021
5.2.2 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue, 2022-2027
5.2.3 By Application - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Autologous Matrix-induced Chondrogenesis Market Size, 2021 & 2027
6.2 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue & Forecasts
6.2.1 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue, 2016-2021
6.2.2 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue, 2022-2027
6.2.3 By Region - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Autologous Matrix-induced Chondrogenesis Revenue, 2016-2027
6.3.2 US Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.3.3 Canada Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.3.4 Mexico Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue, 2016-2027
6.4.2 Germany Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.4.3 France Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.4.4 U.K. Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.4.5 Italy Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.4.6 Russia Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.4.7 Nordic Countries Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.4.8 Benelux Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue, 2016-2027
6.5.2 China Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.5.3 Japan Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.5.4 South Korea Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.5.5 Southeast Asia Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.5.6 India Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Autologous Matrix-induced Chondrogenesis Revenue, 2016-2027
6.6.2 Brazil Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.6.3 Argentina Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue, 2016-2027
6.7.2 Turkey Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.7.3 Israel Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.7.4 Saudi Arabia Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
6.7.5 UAE Autologous Matrix-induced Chondrogenesis Market Size, 2016-2027
7 Players Profiles
7.1 JRI Orthopaedics Ltd
7.1.1 JRI Orthopaedics Ltd Corporate Summary
7.1.2 JRI Orthopaedics Ltd Business Overview
7.1.3 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.1.4 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.1.5 JRI Orthopaedics Ltd Key News
7.2 BioTissue
7.2.1 BioTissue Corporate Summary
7.2.2 BioTissue Business Overview
7.2.3 BioTissue Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.2.4 BioTissue Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.2.5 BioTissue Key News
7.3 Anika Therapeutics
7.3.1 Anika Therapeutics Corporate Summary
7.3.2 Anika Therapeutics Business Overview
7.3.3 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.3.4 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.3.5 Anika Therapeutics Key News
7.4 B. Braun Melsungen
7.4.1 B. Braun Melsungen Corporate Summary
7.4.2 B. Braun Melsungen Business Overview
7.4.3 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.4.4 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.4.5 B. Braun Melsungen Key News
7.5 Arthro-Kinetics
7.5.1 Arthro-Kinetics Corporate Summary
7.5.2 Arthro-Kinetics Business Overview
7.5.3 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.5.4 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.5.5 Arthro-Kinetics Key News
7.6 Geistlich Pharma
7.6.1 Geistlich Pharma Corporate Summary
7.6.2 Geistlich Pharma Business Overview
7.6.3 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.6.4 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.6.5 Geistlich Pharma Key News
7.7 CartiHeal
7.7.1 CartiHeal Corporate Summary
7.7.2 CartiHeal Business Overview
7.7.3 CartiHeal Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.4.4 CartiHeal Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.7.5 CartiHeal Key News
7.8 Matricel
7.8.1 Matricel Corporate Summary
7.8.2 Matricel Business Overview
7.8.3 Matricel Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.8.4 Matricel Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.8.5 Matricel Key News
7.9 Smith & Nephew
7.9.1 Smith & Nephew Corporate Summary
7.9.2 Smith & Nephew Business Overview
7.9.3 Smith & Nephew Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.9.4 Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.9.5 Smith & Nephew Key News
7.10 Zimmer Biomet Holdings
7.10.1 Zimmer Biomet Holdings Corporate Summary
7.10.2 Zimmer Biomet Holdings Business Overview
7.10.3 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Major Product Offerings
7.10.4 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue in Global (2016-2021)
7.10.5 Zimmer Biomet Holdings Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Autologous Matrix-induced Chondrogenesis Market Opportunities & Trends in Global Market
Table 2. Autologous Matrix-induced Chondrogenesis Market Drivers in Global Market
Table 3. Autologous Matrix-induced Chondrogenesis Market Restraints in Global Market
Table 4. Key Players of Autologous Matrix-induced Chondrogenesis in Global Market
Table 5. Top Autologous Matrix-induced Chondrogenesis Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Autologous Matrix-induced Chondrogenesis Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Companies, 2016-2021
Table 8. Global Companies Autologous Matrix-induced Chondrogenesis Product Type
Table 9. List of Global Tier 1 Autologous Matrix-induced Chondrogenesis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Matrix-induced Chondrogenesis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Autologous Matrix-induced Chondrogenesis Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2022-2027
Table 30. JRI Orthopaedics Ltd Corporate Summary
Table 31. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Product Offerings
Table 32. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 33. BioTissue Corporate Summary
Table 34. BioTissue Autologous Matrix-induced Chondrogenesis Product Offerings
Table 35. BioTissue Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 36. Anika Therapeutics Corporate Summary
Table 37. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Product Offerings
Table 38. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 39. B. Braun Melsungen Corporate Summary
Table 40. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Product Offerings
Table 41. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 42. Arthro-Kinetics Corporate Summary
Table 43. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Product Offerings
Table 44. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 45. Geistlich Pharma Corporate Summary
Table 46. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Product Offerings
Table 47. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 48. CartiHeal Corporate Summary
Table 49. CartiHeal Autologous Matrix-induced Chondrogenesis Product Offerings
Table 50. CartiHeal Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 51. Matricel Corporate Summary
Table 52. Matricel Autologous Matrix-induced Chondrogenesis Product Offerings
Table 53. Matricel Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 54. Smith & Nephew Corporate Summary
Table 55. Smith & Nephew Autologous Matrix-induced Chondrogenesis Product Offerings
Table 56. Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
Table 57. Zimmer Biomet Holdings Corporate Summary
Table 58. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Product Offerings
Table 59. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Autologous Matrix-induced Chondrogenesis Segment by Type
Figure 2. Autologous Matrix-induced Chondrogenesis Segment by Application
Figure 3. Global Autologous Matrix-induced Chondrogenesis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Autologous Matrix-induced Chondrogenesis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Autologous Matrix-induced Chondrogenesis Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autologous Matrix-induced Chondrogenesis Revenue in 2020
Figure 8. By Type - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 9. By Application - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 10. By Region - Global Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 11. By Country - North America Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 12. US Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 16. Germany Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 17. France Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 24. China Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 28. India Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 30. Brazil Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share, 2016-2027
Figure 33. Turkey Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Autologous Matrix-induced Chondrogenesis Revenue, (US$, Mn), 2016-2027
Figure 37. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BioTissue Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. CartiHeal Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Matricel Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

JRI Orthopaedics Ltd
BioTissue
Anika Therapeutics
B. Braun Melsungen
Arthro-Kinetics
Geistlich Pharma
CartiHeal
Matricel
Smith & Nephew
Zimmer Biomet Holdings